Compare HWBK & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HWBK | TOI |
|---|---|---|
| Founded | 1865 | 2007 |
| Country | United States | United States |
| Employees | N/A | 641 |
| Industry | Major Banks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.9M | 304.4M |
| IPO Year | 1996 | N/A |
| Metric | HWBK | TOI |
|---|---|---|
| Price | $35.19 | $4.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 5.8K | ★ 1.5M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | ★ 31.42 | N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.15 |
| Revenue Next Year | N/A | $25.77 |
| P/E Ratio | $42.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.07 | $2.02 |
| 52 Week High | $37.30 | $4.88 |
| Indicator | HWBK | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 72.23 |
| Support Level | $32.90 | $3.02 |
| Resistance Level | $35.32 | $4.88 |
| Average True Range (ATR) | 0.84 | 0.26 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 42.18 | 99.37 |
Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, and checking, savings and money market accounts. It has two segments, banking and wealth management, with the banking segment earning the majority of its revenue and conducting general banking business, offering checking and savings accounts, internet banking, debit cards, certificates of deposit, brokerage services and others. Its primary source of revenue is net interest income derived from lending and deposit taking activities.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.